![]() | Only 14 pages are availabe for public view |
Abstract In this work 50 cases of ovarian tumors were studied Histopathologically Immunohistochemically for C-erbB-2 expression Flow cytometric study for DNA ploidy and S-phase fraction from our study we conclude the following: 1- There is extensive expression of C-erbB-2 in epithelial ovarian tumors and it is overexpressed in ovarian carcinoma. 2- The expression of C-erbB-2 in borderline tumors tend to be like that of benign tumors, so these lesions are in fact benign and better classified as proliferative except in the minority they turn frankly malignant. 3- No significant correlation between of C-erbB-2 expression and the clinicopathological parameters including histologic type, tumor grade and tumor stage. 4- C-erbB-2 expression is of importance in patients with ovarian carcinoma who are under therapeutic planes. 5- No significant relation between C-erbB-2 expression and flowcytometric measurementa concerning DNA ploidy, S-phase fraction level and DNA index in ovarian tumors. 6- C-erbB-2 expression in germ cell tumors and sexcord-stromal tumors is indefinite and has no indication 7- Flowcytometric measurements concerning DNA ploidy, S-phase fraction level and DNA index in ovarian tumors are reflective of the biological state of the cell. 8- A fairly good correlation between DNA ploidy, S-phase fration and grade stage of ovarian carcinoma and so it is of value in predicting the prognosis. 9- A fairly good correlation between DNA ploidy and S-phase fraction. |